2 Result: Femasys
OpGen and Femasys: Pre-Market Action Unveiled
September 29th, 2023
Shares of OpGen, Inc. (Nasdaq: OPGN) surged by more than 100% in pre-market trading following a regulatory filing with the Securities and Exchange Commission (SEC), requesting the SEC's consent to withdraw the company's Registration Statement on Form. Read more
FDA Clearance Sparks Femasys Surge; THOR Industries Tops Estimates
September 25th, 2023
Shares of Femasys Inc. (Nasdaq: FEMY) surged by over 100% in after-hours trading following the company's announcement of receiving 510(k) Clearance from the United States Food and Drug Administration (FDA) for its groundbreaking infertility treatment. Read more
Load More Content
Member Login